Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit
A panel of judges in the U.S. Court of Appeals for the Federal Circuit on Wednesday ruled that the lower court was wrong to approve, over objections from Sun, an altered consent judgment filed by Sanofi-Aventis U.S. LLC.
"Sun was... denied the opportunity...
To view the full article, register now.